ACANYA

Compare ACANYA  to:
Compare
Compare

Generic Name for ACANYA

Clindamycin (as phosphate) 1.2%, benzoyl peroxide 2.5%; gel.

Legal Classification:

Rx

Pharmacological Class for ACANYA

Lincosamide antibiotic + antibacterial/keratolytic.

Manufacturer of ACANYA

Arcutis Pharmaceuticals and Coria Laboratories

Indications for ACANYA

Topical treatment of acne vulgaris.

Adult dose for ACANYA

Wash and dry skin. Apply a small (pea-sized) amount in a thin layer to the face once daily. Wash hands after use.

Children's dosing for ACANYA

Not recommended.

Contraindications for ACANYA

History of regional enteritis, ulcerative or antibiotic-associated colitis.

Precautions for ACANYA

Avoid eyes, mucous membranes, broken skin, sun, UV light. Discontinue if significant diarrhea occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions for ACANYA

Avoid concomitant erythromycin. Additive irritation with other topical acne products. May potentiate neuromuscular blocking agents.

Adverse Reactions for ACANYA

Application site pain, exfoliation, irritation; may bleach fabrics or hair; rare: superinfection, colitis.

How is ACANYA supplied?

Gel—50g

Related Disease:

Acne

Related Resources

Restylane-L and Perlane-L dermal fillers approved

February 03, 2010

The FDA has approved Medicis' hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L.

Juvéderm XC dermal filler approved

February 02, 2010

The FDA has approved Juvéderm XC (hyaluronic acid and lidocaine [preservative-free] injectable gel, from Allergan) dermal filler for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (eg, nasolabial folds).

BenzEFoam available for acne vulgaris

October 01, 2009

Onset Therapeutics has launched BenzEFoam (benzoyl peroxide 5.3%) emollient foam for the topical treatment of mild to moderate acne vulgaris.

BenzaClin Carekit launched for acne

August 04, 2009

Dermik Laboratories (a division of sanofi-aventis) announced the launch of the BenzaClin (clindamycin 1%-benzoyl peroxide 5% gel) Carekit for acne patients who want to add a moisturizing agent to their skin care regimen.

Accutane withdrawn from U.S. market

July 15, 2009

Roche Laboratories has announced that it has discontinued the manufacture and distribution of Accutane (isotretinoin capsules).